Biomerica, Inc. (BMRA)

$ 3.755
0.12 (+3.31%)
Symbol BMRA
Price $ 3.755
Beta -0.707
Volume Avg. 0.31M
Market Cap 0.05B
Shares () -
52 Week Range 3.3-9.74
1y Target Est -
DCF Unlevered -
DCF Levered -
ROE -32.77% Strong Sell
ROA -29.79% Sell
Operating Margin -
Debt / Equity 25.93% Neutral
P/E -
P/B 4.21 Strong Buy


Consensus EPS

Upgrades & Downgrades


Mr. Zackary Irani
Diagnostics & Research
Nasdaq Capital Market

Biomerica, Inc. engages in the development, manufacture, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company is headquartered in Irvine, California and currently employs 39 full-time employees. The firm's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The firm operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The firm's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The firm primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The firm's diagnostic products use immunoassay technology.